On April 24, the Indian stock market continued its downward trend, with the Nifty 50 index decreasing by 0.66% to 24,013.75 and the BSE Sensex dropping 0.76% to 77,074.63. This decline marks the third consecutive session of losses, primarily driven by elevated oil prices, which are around $106 per barrel, and a weak performance in the IT sector, notably with Infosys reporting a subdued revenue outlook. Rajesh Palviya, Senior Vice President of Technical and Derivatives Research at Axis Securities, suggests investors consider buying shares of Glenmark Pharmaceuticals, Marico, and Steel Authority of India Ltd (SAIL). Glenmark Pharma, currently priced at ₹2,347, has shown strong bullish signals, with an expected upside of ₹2,455-2,550. Marico, trading at ₹778, has broken past resistance levels with a projected upside of ₹795-810. Meanwhile, SAIL, priced at ₹176, is in a robust uptrend, with an anticipated rise to ₹183-190. Investors are advised to monitor these stocks closely as they exhibit strong momentum and favorable technical indicators.